## JAMES POOL

| | Title| Professor  
---|---  
Institution| Baylor College of Medicine  
Department| Department of Medicine  
Address| 7200 CAMBRIDGE  
Houston, TX 77030  
  
Email|
![](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/EmailHandler.ashx?msg=PLs%2f7mnnIoj4CIrp9Q%3d%3d&rnd=2166e087-bab7-4c9f-991e-2cc2e989eeaa)  
vCard| [Download
vCard](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/vcard.aspx?subject=267284)  
  
![](https://profiles.viictr.org/profile/Modules/CustomViewPersonGeneralInfo/PhotoHandler.ashx?NodeID=267284&cachekey=e1c6d79e-4f13-4bba-83f8-28290dea02d0)  
  

Other Positions| Title| Professor  
---|---  
Institution| Baylor College of Medicine  
Department| Department of Biochemistry and Molecular Pharmacology  
Division| Biochemistry & Mol Pharmacology  
  
  
  
  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
Bibliographic  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
selected publications

Publications listed below are automatically derived from MEDLINE/PubMed and
other sources, which might result in incorrect or missing publications.
Faculty can
[login](https://profiles.viictr.org/loginOptions.aspx?pin=send&method=login&edit=true)
to make corrections and additions.

Newest | Oldest | Most Cited | Most Discussed | Timeline | Field Summary | Plain Text

PMC Citations indicate the number of times the publication was cited by
articles in PubMed Central, and the Altmetric score represents citations in
news articles and social media. (Note that publications are often cited in
additional ways that are not shown here.) Fields are based on how the National
Library of Medicine (NLM) classifies the publication's journal and might not
represent the specific topic of the publication. Translation tags are based on
the publication type and the MeSH terms NLM assigns to the publication. Some
publications (especially newer ones and publications not in PubMed) might not
yet be assigned Field or Translation tags.) Click a Field or Translation tag
to filter the publications.

  1. [Taylor AA](https://profiles.viictr.org/profile/267516), **Pool JL**. Clinical role of direct renin inhibition in hypertension. Am J Ther. 2012 May; 19(3):204-10. PMID: [21317620](//www.ncbi.nlm.nih.gov/pubmed/21317620).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21317620/citedby/) Fields:

The Therapeutics

Translation:Humans

  2. Perlstein TS, Henry RR, Mather KJ, Rickels MR, Abate NI, Grundy SM, Mai Y, Albu JB, Marks JB, **Pool JL** , Creager MA. Effect of angiotensin receptor blockade on insulin sensitivity and endothelial function in abdominally obese hypertensive patients with impaired fasting glucose. Clin Sci (Lond). 2012 Feb; 122(4):193-202. PMID: [21861845](//www.ncbi.nlm.nih.gov/pubmed/21861845); PMCID: [PMC4566948](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4566948).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21861845/citedby/) Fields:

Med Medicine (General)Sci Science

Translation:Humans

  3. Hyman DJ, [Pavlik VN](https://profiles.viictr.org/profile/269512), Greisinger AJ, Chan W, Bayona J, Mansyur C, Simms V, **Pool J**. Effect of a physician uncertainty reduction intervention on blood pressure in uncontrolled hypertensives--a cluster randomized trial. J Gen Intern Med. 2012 Apr; 27(4):413-9. PMID: [22033742](//www.ncbi.nlm.nih.gov/pubmed/22033742); PMCID: [PMC3304039](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3304039).

Citations:
[16](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22033742/citedby/) Fields:

Int Internal Medicine

Translation:Humans

  4. Ferdinand KC, **Pool J** , Weitzman R, Purkayastha D, Townsend R. Peripheral and central blood pressure responses of combination aliskiren/hydrochlorothiazide and amlodipine monotherapy in African American patients with stage 2 hypertension: the ATLAAST trial. J Clin Hypertens (Greenwich). 2011 May; 13(5):366-75. PMID: [21545398](//www.ncbi.nlm.nih.gov/pubmed/21545398); PMCID: [PMC8108786](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8108786).

Citations:
[12](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21545398/citedby/) Fields:

Vas Vascular Diseases

Translation:Humans

  5. [Pavlik VN](https://profiles.viictr.org/profile/269512), Greisinger AJ, **Pool J** , Haidet P, Hyman DJ. Does reducing physician uncertainty improve hypertension control?: rationale and methods. Circ Cardiovasc Qual Outcomes. 2009 May; 2(3):257-63. PMID: [20031846](//www.ncbi.nlm.nih.gov/pubmed/20031846); PMCID: [PMC2780342](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2780342).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20031846/citedby/) Fields:

Car CardiologyVas Vascular Diseases

Translation:Humans

  6. **Pool JL** , Glazer R, Crikelair N, Levy D. The role of baseline blood pressure in guiding treatment choice: a secondary analysis of the use of valsartan/hydrochlorothiazide as initial therapy in hypertensive adults in a randomized, double-blind, placebo-controlled trial. Clin Drug Investig. 2009; 29(12):791-802. PMID: [19888785](//www.ncbi.nlm.nih.gov/pubmed/19888785).

Citations:  Fields:

Dru Drug TherapyPha Pharmacology

Translation:Humans

  7. Friedewald VE, Giles TD, **Pool JL** , Yancy CW, Roberts WC. The Editor's Roundtable: Endothelial dysfunction in cardiovascular disease. Am J Cardiol. 2008 Aug 15; 102(4):418-23. PMID: [18678298](//www.ncbi.nlm.nih.gov/pubmed/18678298).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18678298/citedby/) Fields:

Car Cardiology

Translation:Humans

  8. Oparil S, Abate N, Chen E, Creager MA, Galet V, Jia G, Julius S, Lerman A, Lyle PA, **Pool J** , Tershakovec AM. A double-blind, randomized study evaluating losartan potassium monotherapy or in combination with hydrochlorothiazide versus placebo in obese patients with hypertension. Curr Med Res Opin. 2008 Apr; 24(4):1101-14. PMID: [18328120](//www.ncbi.nlm.nih.gov/pubmed/18328120).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18328120/citedby/) Fields:

Med Medicine (General)

Translation:HumansCTClinical Trials

  9. **Pool JL**. Direct renin inhibition: focus on aliskiren. J Manag Care Pharm. 2007 Oct; 13(8 Suppl B):21-33. PMID: [17970614](//www.ncbi.nlm.nih.gov/pubmed/17970614); PMCID: [PMC10438282](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10438282).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17970614/citedby/) Fields:

Pha Pharmacy

Translation:HumansAnimals

  10. **Pool JL** , Schmieder RE, Azizi M, Aldigier JC, Januszewicz A, Zidek W, Chiang Y, Satlin A. Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan. Am J Hypertens. 2007 Jan; 20(1):11-20. PMID: [17198906](//www.ncbi.nlm.nih.gov/pubmed/17198906).

Citations:
[58](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17198906/citedby/) Fields:

Vas Vascular Diseases

Translation:Humans

  11. **Pool JL** , Glazer R, Weinberger M, Alvarado R, Huang J, Graff A. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults. Clin Ther. 2007 Jan; 29(1):61-73. PMID: [17379047](//www.ncbi.nlm.nih.gov/pubmed/17379047).

Citations:
[24](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17379047/citedby/) Fields:

Dru Drug TherapyThe Therapeutics

Translation:Humans

  12. Wieles B, **Pool J** , Wilke M, Weber M, Kolb HJ, Bontrop RE, Goulmy E. The diallelic locus encoding the minor histocompatibility antigen HA-1 is evolutionarily conserved. Tissue Antigens. 2006 Jul; 68(1):62-5. PMID: [16774541](//www.ncbi.nlm.nih.gov/pubmed/16774541).

Citations:  Fields:

All Allergy and Immunology

Translation:AnimalsCells

  13. Taylor AA, **Pool JL**. Clinical pharmacology of antihypertensive therapy. Semin Nephrol. 2005 Jul; 25(4):215-26. PMID: [16202694](//www.ncbi.nlm.nih.gov/pubmed/16202694).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16202694/citedby/) Fields:

Nep Nephrology

Translation:Humans

  14. **Pool JL**. Is it time to move to multidrug combinations? Am J Hypertens. 2003 Nov; 16(11 Pt 2):36S-40S. PMID: [14625159](//www.ncbi.nlm.nih.gov/pubmed/14625159).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/14625159/citedby/) Fields:

Vas Vascular Diseases

Translation:Humans

  15. **Pool J** , Kaihlanen P, Lewis G, Ginsberg D, Oparil S, Glazer R, Messerli FH. Once-daily treatment of patients with hypertension: a placebo-controlled study of amlodipine and benazepril vs amlodipine or benazepril alone. J Hum Hypertens. 2001 Jul; 15(7):495-8. PMID: [11464260](//www.ncbi.nlm.nih.gov/pubmed/11464260).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11464260/citedby/) Fields:

Vas Vascular Diseases

Translation:HumansCTClinical Trials

  16. Kloner RA, Weinberger M, **Pool JL** , Chrysant SG, Prasad R, Harris SM, Zyczynski TM, Leidy NK, Michelson EL, Comparison of Candesartan and Amlodipine for Safety, Tolerability and Efficacy (CASTLE) Study Invest. Comparative effects of candesartan cilexetil and amlodipine in patients with mild systemic hypertension. Comparison of Candesartan and Amlodipine for Safety, Tolerability and Efficacy (CASTLE) Study Investigators. Am J Cardiol. 2001 Mar 15; 87(6):727-31. PMID: [11249891](//www.ncbi.nlm.nih.gov/pubmed/11249891).

Citations:
[15](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11249891/citedby/) Fields:

Car Cardiology

Translation:HumansCTClinical Trials

  17. **Pool JL** , Kirby RS. Clinical significance of alpha1-adrenoceptor selectivity in the management of benign prostatic hyperplasia. Int Urol Nephrol. 2001; 33(3):407-12. PMID: [12230262](//www.ncbi.nlm.nih.gov/pubmed/12230262).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12230262/citedby/) Fields:

Nep NephrologyUro Urology

Translation:Humans

  18. Kirby RS, **Pool JL**. Interpretation of the ALLHAT interim analysis and implications for the treatment of patients with BPH. Prostate Cancer Prostatic Dis. 2000 Nov; 3(3):152-156. PMID: [12497091](//www.ncbi.nlm.nih.gov/pubmed/12497091).

Citations:  Fields:

Neo NeoplasmsUro Urology

  19. **Pool JL**. The role of angiotensin II in hypertension and end-organ damage. Int J Clin Pract Suppl. 2000 Aug; (111):4-8. PMID: [15977400](//www.ncbi.nlm.nih.gov/pubmed/15977400).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15977400/citedby/) Fields:

Med Medicine (General)

Translation:HumansAnimals

  20. Sica DA, **Pool JL**. Current Concepts of Pharmacotherapy in Hypertension - Alpha-Adrenergic Blocking Drugs: Evolving Role in Clinical Medicine. J Clin Hypertens (Greenwich). 2000 Mar; 2(2):138-142. PMID: [11416638](//www.ncbi.nlm.nih.gov/pubmed/11416638).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11416638/citedby/) Fields:

Vas Vascular Diseases

  21. Taylor AA, Shepherd AM, Polvino W, Mangoo-Karim R, Ballard K, Sunthornyothin S, Luther RR, **Pool JL**. Prolonged fenoldopam infusions in patients with mild to moderate hypertension: pharmacodynamic and pharmacokinetic effects. Am J Hypertens. 1999 Sep; 12(9 Pt 1):906-14. PMID: [10509549](//www.ncbi.nlm.nih.gov/pubmed/10509549).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/10509549/citedby/) Fields:

Vas Vascular Diseases

Translation:HumansCTClinical Trials

  22. Taylor AA, Mangoo-Karim R, Ballard KD, Luther RR, **Pool JL**. Sustained hemodynamic effects of the selective dopamine-1 agonist, fenoldopam, during 48-hour infusions in hypertensive patients: a dose-tolerability study. J Clin Pharmacol. 1999 May; 39(5):471-9. PMID: [10234594](//www.ncbi.nlm.nih.gov/pubmed/10234594).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/10234594/citedby/) Fields:

Pha Pharmacology

Translation:Humans

  23. **Pool JL** , Glazer R, Chiang YT, Gatlin M. Dose-response efficacy of valsartan, a new angiotensin II receptor blocker. J Hum Hypertens. 1999 Apr; 13(4):275-81. PMID: [10333347](//www.ncbi.nlm.nih.gov/pubmed/10333347).

Citations:
[14](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/10333347/citedby/) Fields:

Vas Vascular Diseases

Translation:HumansCTClinical Trials

  24. **Pool J** , Oparil S, Hedner T, Glazer R, Oddou-Stock P, Hester A. Dose-responsive antihypertensive efficacy of valsartan, a new angiotensin II-receptor blocker. Clin Ther. 1998 Nov-Dec; 20(6):1106-14. PMID: [9916605](//www.ncbi.nlm.nih.gov/pubmed/9916605).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9916605/citedby/) Fields:

Dru Drug TherapyThe Therapeutics

Translation:HumansCTClinical Trials

  25. **Pool JL** , Guthrie RM, Littlejohn TW, Raskin P, Shephard AM, Weber MA, Weir MR, Wilson TW, Wright J, Kassler-Taub KB, Reeves RA. Dose-related antihypertensive effects of irbesartan in patients with mild-to-moderate hypertension. Am J Hypertens. 1998 Apr; 11(4 Pt 1):462-70. PMID: [9607385](//www.ncbi.nlm.nih.gov/pubmed/9607385).

Citations:
[20](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9607385/citedby/) Fields:

Vas Vascular Diseases

Translation:HumansCTClinical Trials

  26. **Pool JL** , Svetkey L, Gradman AH, Larochelle P, de Champlain J, Smith WB, Lacourci?re Y. A randomized, double-blind, placebo-controlled, parallel-group, multicenter trial of four doses of tasosartan in patients with essential hypertension. Tasosartan Investigator's Group. Am J Hypertens. 1998 Apr; 11(4 Pt 1):454-61. PMID: [9607384](//www.ncbi.nlm.nih.gov/pubmed/9607384).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9607384/citedby/) Fields:

Vas Vascular Diseases

Translation:HumansCTClinical Trials

  27. Kirby RS, **Pool JL**. Alpha adrenoceptor blockade in the treatment of benign prostatic hyperplasia: past, present and future. Br J Urol. 1997 Oct; 80(4):521-32. PMID: [9352686](//www.ncbi.nlm.nih.gov/pubmed/9352686).

Citations:
[11](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9352686/citedby/) Fields:

Uro Urology

Translation:Humans

  28. Neutel J, Weber M, **Pool J** , Smith D, Fitzsimmons S, Chiang YT, Gatlin M. Valsartan, a new angiotensin II antagonist: antihypertensive effects over 24 hours. Clin Ther. 1997 May-Jun; 19(3):447-58; discussion 367-8. PMID: [9220209](//www.ncbi.nlm.nih.gov/pubmed/9220209).

Citations:
[11](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9220209/citedby/) Fields:

Dru Drug TherapyThe Therapeutics

Translation:HumansCTClinical Trials

  29. **Pool JL** , Cushman WC, Saini RK, Nwachuku CE, Battikha JP. Use of the factorial design and quadratic response surface models to evaluate the fosinopril and hydrochlorothiazide combination therapy in hypertension. Am J Hypertens. 1997 Jan; 10(1):117-23. PMID: [9008256](//www.ncbi.nlm.nih.gov/pubmed/9008256).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9008256/citedby/) Fields:

Vas Vascular Diseases

Translation:HumansCTClinical Trials

  30. **Pool JL**. Doxazosin: a new approach to hypertension and benign prostatic hyperplasia. Br J Clin Pract. 1996 Apr-May; 50(3):154-63. PMID: [8733335](//www.ncbi.nlm.nih.gov/pubmed/8733335).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/8733335/citedby/) Fields:

Med Medicine (General)

Translation:Humans

  31. Lenz ML, **Pool JL** , Laddu AR, Varghese A, Johnston W, Taylor AA. Combined terazosin and verapamil therapy in essential hypertension. Hemodynamic and pharmacokinetic interactions. Am J Hypertens. 1995 Feb; 8(2):133-45. PMID: [7755941](//www.ncbi.nlm.nih.gov/pubmed/7755941).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/7755941/citedby/) Fields:

Vas Vascular Diseases

Translation:HumansCTClinical Trials

  32. Bradford RH, Shear CL, Chremos AN, Dujovne CA, Franklin FA, Grillo RB, Higgins J, Langendorfer A, Nash DT, **Pool JL** , et al. Expanded Clinical Evaluation of Lovastatin (EXCEL) study results: two-year efficacy and safety follow-up. Am J Cardiol. 1994 Oct 01; 74(7):667-73. PMID: [7942524](//www.ncbi.nlm.nih.gov/pubmed/7942524).

Citations:
[22](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/7942524/citedby/) Fields:

Car Cardiology

Translation:HumansCTClinical Trials

  33. **Pool JL**. Effects of doxazosin on coronary heart disease risk factors in the hypertensive patient. Br J Clin Pract Suppl. 1994 May; 74:8-12. PMID: [8049119](//www.ncbi.nlm.nih.gov/pubmed/8049119).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/8049119/citedby/) Fields:

Dru Drug TherapyMed Medicine (General)

Translation:Humans

  34. **Pool JL**. Role of the sympathetic nervous system in hypertension and benign prostatic hyperplasia. Br J Clin Pract Suppl. 1994 May; 74:13-7. PMID: [7519436](//www.ncbi.nlm.nih.gov/pubmed/7519436).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/7519436/citedby/) Fields:

Dru Drug TherapyMed Medicine (General)

Translation:Humans

  35. Black HR, Chrysant SG, Curry CL, Frishman WH, Grimm RH, Lasseter KC, Okun R, **Pool JL** , Raizada V, Vlachakis ND, et al. Antihypertensive and metabolic effects of concomitant administration of terazosin and methyclothiazide for the treatment of essential hypertension. J Clin Pharmacol. 1992 Apr; 32(4):351-9. PMID: [1349028](//www.ncbi.nlm.nih.gov/pubmed/1349028).

Citations:  Fields:

Pha Pharmacology

Translation:HumansCTClinical Trials

  36. **Pool JL** , Shear CL, Downton M, Schnaper H, Stinnett S, Dujovne C, Bradford RH, Chremos AN. Lovastatin and coadministered antihypertensive/cardiovascular agents. Hypertension. 1992 Mar; 19(3):242-8. PMID: [1347757](//www.ncbi.nlm.nih.gov/pubmed/1347757).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1347757/citedby/) Fields:

Vas Vascular Diseases

Translation:HumansCTClinical Trials

  37. **Pool JL**. Combination antihypertensive therapy with terazosin and other antihypertensive agents: results of clinical trials. Am Heart J. 1991 Sep; 122(3 Pt 2):926-31. PMID: [1678924](//www.ncbi.nlm.nih.gov/pubmed/1678924).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1678924/citedby/) Fields:

Car Cardiology

Translation:HumansCTClinical Trials

  38. Dujovne CA, Chremos AN, **Pool JL** , Schnaper H, Bradford RH, Shear CL, Higgins J, Downton M, Franklin FA, Nash DT, et al. Expanded clinical evaluation of lovastatin (EXCEL) study results: IV. Additional perspectives on the tolerability of lovastatin. Am J Med. 1991 Jul 31; 91(1B):25S-30S. PMID: [1831006](//www.ncbi.nlm.nih.gov/pubmed/1831006).

Citations:
[18](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1831006/citedby/) Fields:

Med Medicine (General)

Translation:HumansCTClinical Trials

  39. Bradford RH, Shear CL, Chremos AN, Franklin FA, Nash DT, Hurley DP, Dujovne CA, **Pool JL** , Schnaper H, Hesney M, et al. Expanded clinical evaluation of lovastatin (EXCEL) study results: III. Efficacy in modifying lipoproteins and implications for managing patients with moderate hypercholesterolemia. Am J Med. 1991 Jul 31; 91(1B):18S-24S. PMID: [1867232](//www.ncbi.nlm.nih.gov/pubmed/1867232).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1867232/citedby/) Fields:

Med Medicine (General)

Translation:HumansCTClinical Trials

  40. Weir MR, Josselson J, Ekelund LG, Korc M, **Pool JL** , Stein GH, Wolbach RA, Champion D. Nicardipine as antihypertensive monotherapy: positive effects on quality of life. J Hum Hypertens. 1991 Jun; 5(3):205-13. PMID: [1920344](//www.ncbi.nlm.nih.gov/pubmed/1920344).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1920344/citedby/) Fields:

Vas Vascular Diseases

Translation:HumansCTClinical Trials

  41. **Pool JL**. Effects of doxazosin on serum lipids: a review of the clinical data and molecular basis for altered lipid metabolism. Am Heart J. 1991 Jan; 121(1 Pt 2):251-9; discussion 259-60. PMID: [1824647](//www.ncbi.nlm.nih.gov/pubmed/1824647).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1824647/citedby/) Fields:

Car Cardiology

Translation:Humans

  42. **Pool JL**. Antihypertensive effect of fosinopril, a new angiotensin converting enzyme inhibitor: findings of the Fosinopril Study Group II. Clin Ther. 1990 Nov-Dec; 12(6):520-33. PMID: [2149674](//www.ncbi.nlm.nih.gov/pubmed/2149674).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/2149674/citedby/) Fields:

Dru Drug TherapyThe Therapeutics

Translation:HumansCTClinical Trials

  43. **Pool JL** , Lenz ML, Taylor AA. Alpha 1-adrenoreceptor blockade and the molecular basis of lipid metabolism alterations. J Hum Hypertens. 1990 Oct; 4 Suppl 3:23-33. PMID: [1979819](//www.ncbi.nlm.nih.gov/pubmed/1979819).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1979819/citedby/) Fields:

Vas Vascular Diseases

Translation:HumansCells

  44. Bradford RH, Shear CL, Chremos AN, Dujovne C, Franklin FA, Hesney M, Higgins J, **Pool JL** , Schnaper H, Langend?rfer A, et al. Expanded clinical evaluation of lovastatin (EXCEL) study: design and patient characteristics of a double-blind, placebo-controlled study in patients with moderate hypercholesterolemia. Am J Cardiol. 1990 Sep 18; 66(8):44B-55B. PMID: [2206036](//www.ncbi.nlm.nih.gov/pubmed/2206036).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/2206036/citedby/) Fields:

Car Cardiology

Translation:HumansCTClinical Trials

  45. **Pool JL** , Taylor AA, Nelson EB. Review of the effects of doxazosin, a new selective alpha 1-adrenergic inhibitor, on lipoproteins in patients with essential hypertension. Am J Med. 1989 Aug 16; 87(2A):57S-61S. PMID: [2569825](//www.ncbi.nlm.nih.gov/pubmed/2569825).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/2569825/citedby/) Fields:

Med Medicine (General)

Translation:Humans

  46. Taylor AA, Davies AO, Mares A, Raschko J, **Pool JL** , Nelson EB, Mitchell JR. Spectrum of dysautonomia in mitral valvular prolapse. Am J Med. 1989 Mar; 86(3):267-74. PMID: [2919608](//www.ncbi.nlm.nih.gov/pubmed/2919608).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/2919608/citedby/) Fields:

Med Medicine (General)

Translation:Humans

  47. Crawford ES, Coselli JS, Safi HJ, Martin TD, **Pool JL**. The impact of renal fusion and ectopia on aortic surgery. J Vasc Surg. 1988 Oct; 8(4):375-83. PMID: [3172375](//www.ncbi.nlm.nih.gov/pubmed/3172375).

Citations:
[12](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/3172375/citedby/) Fields:

Gen General SurgeryVas Vascular Diseases

Translation:Humans

  48. **Pool JL** , Nelson EB, Taylor AA. Clinical experience and rationale for angiotensin-converting enzyme inhibition with lisinopril as the initial treatment for hypertension in older patients. Am J Med. 1988 Sep 23; 85(3B):19-24. PMID: [2844082](//www.ncbi.nlm.nih.gov/pubmed/2844082).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/2844082/citedby/) Fields:

Med Medicine (General)

Translation:Humans

  49. Cubeddu LX, **Pool JL** , Bloomfield R, [Klotman PE](https://profiles.viictr.org/profile/266613), Pickering BI, Wombolt DG, Nelson EB, Halperin A. Effect of doxazosin monotherapy on blood pressure and plasma lipids in patients with essential hypertension. Am J Hypertens. 1988 Apr; 1(2):158-67. PMID: [2969740](//www.ncbi.nlm.nih.gov/pubmed/2969740).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/2969740/citedby/) Fields:

Vas Vascular Diseases

Translation:HumansCTClinical Trials

  50. Goldfarb R, **Pool JL** , [Wheeler T](https://profiles.viictr.org/profile/266558). Isolated renal artery dissection secondary to medial degeneration. J Urol. 1988 Feb; 139(2):346-7. PMID: [3339739](//www.ncbi.nlm.nih.gov/pubmed/3339739).

Citations:  Fields:

Uro Urology

Translation:Humans

  51. **Pool JL** , Nelson EB, Taylor AA, Mitchell JR. Terazosin (Hytrin): cumulative experience of clinical trials in the USA for the treatment of mild to moderate essential hypertension. Br J Clin Pract Suppl. 1987 Dec; 54:9-14. PMID: [2905162](//www.ncbi.nlm.nih.gov/pubmed/2905162).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/2905162/citedby/) Fields:

Dru Drug TherapyMed Medicine (General)

Translation:HumansCTClinical Trials

  52. Simpson RK, **Pool JL** , Grossman RG, Rose JE, Taylor AA. Neurosurgical management of carotid sinus hypersensitivity. Report of three cases. J Neurosurg. 1987 Nov; 67(5):757-9. PMID: [3668646](//www.ncbi.nlm.nih.gov/pubmed/3668646).

Citations:  Fields:

Neu Neurosurgery

Translation:Humans

  53. Schmedtje JF, Sax S, **Pool JL** , Goldfarb RA, Nelson EB. Localization of ectopic pheochromocytomas by magnetic resonance imaging. Am J Med. 1987 Oct; 83(4):770-2. PMID: [3674064](//www.ncbi.nlm.nih.gov/pubmed/3674064).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/3674064/citedby/) Fields:

Med Medicine (General)

Translation:Humans

  54. **Pool JL**. Plasma lipid lowering effects of doxazosin, a new selective alpha1 adrenergic inhibitor for systemic hypertension. Am J Cardiol. 1987 May 29; 59(14):46G-50G. PMID: [2884853](//www.ncbi.nlm.nih.gov/pubmed/2884853).

Citations:  Fields:

Car Cardiology

Translation:HumansCTClinical Trials

  55. Davies AO, Mares A, **Pool JL** , Taylor AA. Mitral valve prolapse with symptoms of beta-adrenergic hypersensitivity. Beta 2-adrenergic receptor supercoupling with desensitization on isoproterenol exposure. Am J Med. 1987 Feb; 82(2):193-201. PMID: [3028141](//www.ncbi.nlm.nih.gov/pubmed/3028141).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/3028141/citedby/) Fields:

Med Medicine (General)

Translation:HumansCells

  56. **Pool JL** , Gennari J, Goldstein R, Kochar MS, Lewin AJ, Maxwell MH, McChesney JA, Mehta J, Nash DT, Nelson EB, et al. Controlled multicenter study of the antihypertensive effects of lisinopril, hydrochlorothiazide, and lisinopril plus hydrochlorothiazide in the treatment of 394 patients with mild to moderate essential hypertension. J Cardiovasc Pharmacol. 1987; 9 Suppl 3:S36-42. PMID: [2442550](//www.ncbi.nlm.nih.gov/pubmed/2442550).

Citations:
[18](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/2442550/citedby/) Fields:

Car CardiologyPha Pharmacology

Translation:HumansCTClinical Trials

  57. Nelson EB, **Pool JL** , Taylor AA. Antihypertensive activity of isradipine in humans: a new dihydropyridine calcium channel antagonist. Clin Pharmacol Ther. 1986 Dec; 40(6):694-7. PMID: [2946507](//www.ncbi.nlm.nih.gov/pubmed/2946507).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/2946507/citedby/) Fields:

Dru Drug TherapyPha Pharmacology

Translation:HumansCTClinical Trials

  58. Nelson EB, **Pool JL** , Taylor AA. Pharmacology of angiotensin converting enzyme inhibitors. A review. Am J Med. 1986 Oct 31; 81(4C):13-8. PMID: [3022580](//www.ncbi.nlm.nih.gov/pubmed/3022580).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/3022580/citedby/) Fields:

Med Medicine (General)

Translation:HumansCells

  59. Schwartz JB, Taylor A, Abernethy D, O'Meara M, Farmer J, Young J, Nelson E, **Pool J** , Mitchell JR. Pharmacokinetics and pharmacodynamics of enalapril in patients with congestive heart failure and patients with hypertension. J Cardiovasc Pharmacol. 1985 Jul-Aug; 7(4):767-76. PMID: [2410720](//www.ncbi.nlm.nih.gov/pubmed/2410720).

Citations:
[17](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/2410720/citedby/) Fields:

Car CardiologyPha Pharmacology

Translation:HumansCTClinical Trials

  60. Taylor AA, Fennell WH, Ruud CO, **Pool JL** , Nelson EB, Ginos JZ, Mitchell JR. Propylbutyldopamine. Mechanism of blood pressure lowering in hypertensive patients. Hypertension. 1984 Mar-Apr; 6(2 Pt 2):I40-5. PMID: [6373598](//www.ncbi.nlm.nih.gov/pubmed/6373598).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/6373598/citedby/) Fields:

Vas Vascular Diseases

Translation:HumansCTClinical Trials

  61. Taburet AM, Taylor AA, Mitchell JR, Rollins DE, **Pool JL**. Plasma concentrations of propranolol and 4-hydroxypropranolol in man measured by high pressure liquid chromatography. Life Sci. 1979 Jan 15; 24(3):209-17. PMID: [423699](//www.ncbi.nlm.nih.gov/pubmed/423699).

Citations: [4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/423699/citedby/)
Fields:

Bio BiochemistryBio BiologyPhy Physiology

Translation:HumansCells

  62. Taylor AA, **Pool JL** , Lake CR, Ziegler MG, Rosen RA, Rollins DE, Mitchell JR. Plasma norepinephrine concentrations: no differences among normal volunteers and low, high or normal renin hypertensive patients. Life Sci. 1978 May 01; 22(17):1499-510. PMID: [672409](//www.ncbi.nlm.nih.gov/pubmed/672409).

Citations: [2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/672409/citedby/)
Fields:

Bio BiochemistryBio BiologyPhy Physiology

Translation:Humans

  63. Mitchell JR, Taylor AA, **Pool JL** , Lake CR, Rollins DE, Bartter FC. Renin-aldosterone profiling in hypertension. Ann Intern Med. 1977 Nov; 87(5):596-312. PMID: [335942](//www.ncbi.nlm.nih.gov/pubmed/335942).

Citations: [5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/335942/citedby/)
Fields:

Int Internal Medicine

Translation:HumansCTClinical Trials

  64. Meilink-Hoedemaker LJ, **Pool J** , Muste-Heijns MM. A double-blind placebo-controlled cross-over study with lidoflazine (Clinium) in post-infarction patients. Acta Med Scand. 1976; 199(1-2):17-23. PMID: [766572](//www.ncbi.nlm.nih.gov/pubmed/766572).

Citations:  Fields:

Med Medicine (General)

Translation:HumansCTClinical Trials

  65. **Pool JL**. Muslin gauze in intracranial vascular surgery. Technical note. J Neurosurg. 1976 Jan; 44(1):127-8. PMID: [1244428](//www.ncbi.nlm.nih.gov/pubmed/1244428).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1244428/citedby/) Fields:

Neu Neurosurgery

Translation:Humans

  66. **Pool JL**. Henry L. Heyl, 1906-1975. J Neurosurg. 1975 Jun; 42(6):625-7. PMID: [1095692](//www.ncbi.nlm.nih.gov/pubmed/1095692).

Citations:  Fields:

Neu Neurosurgery

  67. **Pool JL**. Bifrontal craniotomy for anterior communicating artery aneurysms. J Neurosurg. 1972 Feb; 36(2):212-20. PMID: [5008735](//www.ncbi.nlm.nih.gov/pubmed/5008735).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/5008735/citedby/) Fields:

Neu Neurosurgery

Translation:Humans

  68. **Pool JL**. Excision of cerebral arteriovenous malformations. J Neurosurg. 1968 Sep; 29(3):312-21. PMID: [5684412](//www.ncbi.nlm.nih.gov/pubmed/5684412).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/5684412/citedby/) Fields:

Neu Neurosurgery

Translation:Humans

  69. **Pool JL**. Gliomas in the region of the brain stem. J Neurosurg. 1968 Aug; 29(2):164-7. PMID: [5673314](//www.ncbi.nlm.nih.gov/pubmed/5673314).

Citations:
[14](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/5673314/citedby/) Fields:

Neu Neurosurgery

Translation:Humans

  70. McMurtry JG, **Pool JL** , Nova HR. The use of rheomacrodex in the surgery of intracranial aneurysms. J Neurosurg. 1967 Feb; 26(2):218-22. PMID: [6018581](//www.ncbi.nlm.nih.gov/pubmed/6018581).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/6018581/citedby/) Fields:

Neu Neurosurgery

Translation:HumansAnimals

  71. **Pool JL** , Colton RP. The dissecting microscope for intracranial vascular surgery. J Neurosurg. 1966 Sep; 25(3):315-8. PMID: [5921324](//www.ncbi.nlm.nih.gov/pubmed/5921324).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/5921324/citedby/) Fields:

Neu Neurosurgery

  72. **Pool JL**. Suboccipital surgery for acoustic neurinomas: advantages and disadvantages. J Neurosurg. 1966 Feb; 24(2):483-92. PMID: [5935378](//www.ncbi.nlm.nih.gov/pubmed/5935378).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/5935378/citedby/) Fields:

Neu Neurosurgery

Translation:Humans

  73. STEIN BM, LEEDS NE, TAVERAS JM, **POOL JL**. MENINGIOMAS OF THE FORAMEN MAGNUM. J Neurosurg. 1963 Sep; 20:740-51. PMID: [14184992](//www.ncbi.nlm.nih.gov/pubmed/14184992).

Citations:
[20](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/14184992/citedby/) Fields:

Neu Neurosurgery

Translation:Humans

  74. **POOL JL**. Timing and techniques in the intracranial surgery of ruptured aneurysms of the anterior communicating artery. J Neurosurg. 1962 May; 19:378-88. PMID: [14487836](//www.ncbi.nlm.nih.gov/pubmed/14487836).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/14487836/citedby/) Fields:

Neu Neurosurgery

Translation:Humans

  75. **POOL JL**. Treatment of arteriovenous malformations of the cerebral hemispheres. J Neurosurg. 1962 Feb; 19:136-41. PMID: [14487838](//www.ncbi.nlm.nih.gov/pubmed/14487838).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/14487838/citedby/) Fields:

Neu Neurosurgery

Translation:Humans

  76. **POOL JL** , POTANOS JN, KRUEGER EG. Osteomas and mucoceles of the frontal paranasal sinuses. J Neurosurg. 1962 Feb; 19:130-5. PMID: [14487830](//www.ncbi.nlm.nih.gov/pubmed/14487830).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/14487830/citedby/) Fields:

Neu Neurosurgery

Translation:Humans

  77. RANSOHOFF J, POTANOS J, BOSCHENSTEIN F, **POOL JL**. Total removal of recurrent acoustic tumors. J Neurosurg. 1961 Nov; 18:804-10. PMID: [14490297](//www.ncbi.nlm.nih.gov/pubmed/14490297).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/14490297/citedby/) Fields:

Neu Neurosurgery

Translation:Humans

  78. **POOL JL**. Aneurysms of the anterior communicating artery. Bifrontal craniotomy and routine use of temporary clips. J Neurosurg. 1961 Jan; 18:98-112. PMID: [13737059](//www.ncbi.nlm.nih.gov/pubmed/13737059).

Citations:
[15](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/13737059/citedby/) Fields:

Neu Neurosurgery

Translation:Humans

  79. **POOL JL** , KESSLER LA. Mechanism and control of centrally induced cardiac irregularities during hypothermia. I. Clinical observations. J Neurosurg. 1958 Jan; 15(1):52-64. PMID: [13492075](//www.ncbi.nlm.nih.gov/pubmed/13492075).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/13492075/citedby/) Fields:

Neu Neurosurgery

Translation:Humans

  80. **POOL JL**. Unilateral thoracic hyperhidrosis caused by osteoma of the tenth dorsal vertebra; case report. J Neurosurg. 1956 Jan; 13(1):111-5. PMID: [13286733](//www.ncbi.nlm.nih.gov/pubmed/13286733).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/13286733/citedby/) Fields:

Neu Neurosurgery

Translation:Humans

  81. **POOL JL**. The visceral brain of man. J Neurosurg. 1954 Jan; 11(1):45-63. PMID: [13131094](//www.ncbi.nlm.nih.gov/pubmed/13131094).

Citations:
[12](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/13131094/citedby/) Fields:

Neu Neurosurgery

Translation:Humans

  82. GLUSMAN M, RANSOHOFF J, **POOL JL** , GRUNDFEST H, METTLER FA. Electrical excitability of the human motor cortex. I. The parameters of the electrical stimulus. J Neurosurg. 1952 Sep; 9(5):461-71. PMID: [12981568](//www.ncbi.nlm.nih.gov/pubmed/12981568).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12981568/citedby/) Fields:

Neu Neurosurgery

Translation:Humans

  83. **POOL JL** , BRABSON JA. Pain in stimulating the distal segment of divided peripheral nerves. J Neurosurg. 1946 Nov; 3(6):468-73. PMID: [20279143](//www.ncbi.nlm.nih.gov/pubmed/20279143).

Citations:  Fields:

Neu Neurosurgery

Translation:Humans

  84. SCARFF JE, **POOL JL**. Factors causing massive spasm following transection of the cord in man. J Neurosurg. 1946 Jul; 3:285-93. PMID: [20989177](//www.ncbi.nlm.nih.gov/pubmed/20989177).

Citations:  Fields:

Neu Neurosurgery

Translation:Humans

  85. **POOL JL** , TURNER OA. Ependymoma of spinal cord; subtotal intramedullary removal from syringomyelic cavity. J Neurosurg. 1946 Jul; 3:348-51. PMID: [20989184](//www.ncbi.nlm.nih.gov/pubmed/20989184).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20989184/citedby/) Fields:

Neu Neurosurgery

Translation:Humans

  86. **POOL JL**. Nerve stimulation in paraplegic patients by means of buried induction coil; preliminary report. J Neurosurg. 1946 May; 3:264-7. PMID: [21026951](//www.ncbi.nlm.nih.gov/pubmed/21026951).

Citations:  Fields:

Neu Neurosurgery

Translation:Humans

  87. **POOL JL**. Electrospinogram (ESG); spinal cord action potentials recorded from a paraplegic patient. J Neurosurg. 1946 May; 3:192-8. PMID: [21026940](//www.ncbi.nlm.nih.gov/pubmed/21026940).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21026940/citedby/) Fields:

Neu Neurosurgery

Translation:Humans

This graph shows the total number of publications by year. To see the data as
text, click here.

![Bar chart showing 34 publications over 16 distinct years, with a maximum of
3 publications in 1994 and 1997 and 1998 and 1999 and 2000 and 2001 and
2007](//chart.googleapis.com/chart?chs=595x100&chf=bg,s,ffffff|c,s,ffffff&chxt=x,y&chxl=0:|'94||'96||'98||'00||'02||'04||'06||'08||'10||'12||'14||'16||'18||'20||'22||'24|1:|0|3&cht=bvs&chd=t:100,33,33,100,100,100,100,100,0,33,0,33,33,100,67,67,0,67,67,0,0,0,0,0,0,0,0,0,0,0,0&chdl=Publications&chco=80B1D3&chbh=10)

This graph shows the total number of publications by year. To return to the
graph, click here.

Year| Publications  
---|---  
1994| 3  
1995| 1  
1996| 1  
1997| 3  
1998| 3  
1999| 3  
2000| 3  
2001| 3  
2003| 1  
2005| 1  
2006| 1  
2007| 3  
2008| 2  
2009| 2  
2011| 2  
2012| 2  
  
This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

Start with: newest oldest Include: line numbers double spacing all authors
publication IDs

POOL's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (314)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

Derived automatically from this person's publications.

  * [Antihypertensive Agents](https://profiles.viictr.org/profile/259302)
  * [Hypertension](https://profiles.viictr.org/profile/252125)
  * [Tetrazoles](https://profiles.viictr.org/profile/265100)
  * [Hydrochlorothiazide](https://profiles.viictr.org/profile/257192)
  * [Valine](https://profiles.viictr.org/profile/241763)

[Explore](https://profiles.viictr.org/profile/267284/198)

_

Co-Authors (4)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People in Profiles who have published with this person.

  * [TAYLOR, ADDISON](https://profiles.viictr.org/profile/267516)
  * [PAVLIK, VALORY](https://profiles.viictr.org/profile/269512)
  * [WHEELER, THOMAS](https://profiles.viictr.org/profile/266558)
  * [KLOTMAN, PAUL](https://profiles.viictr.org/profile/266613)

[Explore](https://profiles.viictr.org/profile/267284/345)

_

Similar People (60)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People who share similar concepts with this person.

  * [BOERWINKLE, ERIC](https://profiles.viictr.org/profile/267689)
  * [VIRANI, SALIM](https://profiles.viictr.org/profile/268389)
  * [BALLANTYNE, CHRISTIE](https://profiles.viictr.org/profile/266404)
  * [PAN, HUI-LIN](https://profiles.viictr.org/profile/12583081)
  * [ABUGHOSH, SUSAN](https://profiles.viictr.org/profile/267587)

[Explore](https://profiles.viictr.org/profile/267284/476)

_

Same Department [ ![Expand
Description](https://profiles.viictr.org/Framework/Images/info.png)
](JavaScript:toggleVisibility\('sdDescript'\);)

People who are also in this person's primary department.

  * [FARRELL, JESSICA](https://profiles.viictr.org/profile/16255210)
  * [HOU, JASON](https://profiles.viictr.org/profile/270204)
  * [SALGIA, ALOK](https://profiles.viictr.org/profile/31713849)
  * [TAVAKOLI TABASI, SHAHRIAR](https://profiles.viictr.org/profile/269412)
  * [TAYLOR, ADDISON](https://profiles.viictr.org/profile/267516)

[Explore](https://profiles.viictr.org/search/default.aspx?searchtype=people&searchfor=&SearchRequest=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)

_

Physical Neighbors
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People whose addresses are nearby this person.

  * [CHAN, WENYAW](https://profiles.viictr.org/profile/265504)
  * [RAGHAVAN, RAJEEV](https://profiles.viictr.org/profile/268946)
  * [ROSE, STACEY](https://profiles.viictr.org/profile/269164)
  * [SARIDEY, SAI](https://profiles.viictr.org/profile/265783)
  * [TAYLOR, ADDISON](https://profiles.viictr.org/profile/267516)

_

